• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒复制受 HIV-1 亚型间重组衍生的 Vpu 蛋白增强。

Viral replication is enhanced by an HIV-1 intersubtype recombination-derived Vpu protein.

机构信息

National Reference Center for AIDS, Department of Microbiology, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina.

出版信息

Virol J. 2010 Oct 4;7:259. doi: 10.1186/1743-422X-7-259.

DOI:10.1186/1743-422X-7-259
PMID:20920359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2967538/
Abstract

BACKGROUND

Multiple HIV-1 intersubtype recombinants have been identified in human populations. Previous studies from our lab group have shown that the epidemic in Argentina is characterized by the high prevalence of a circulating recombinant form, CRF12_BF, and many related BF recombinant forms. In these genomic structures a recombination breakpoint frequently involved the vpu coding region. Due to the scarce knowledge of Vpu participation in the virion release process and its impact on pathogenesis and of the functional capacities of intersubtype recombinant Vpu proteins, the aim of this work was to perform a comparative analysis on virion release capacity and relative replication capacity among viral variants harboring either a BF recombinant Vpu or a subtype B Vpu.

RESULTS

Our results showed that BF recombinant Vpu was associated to an increased viral particles production when compared to WT B variant in tetherin-expressing cell lines. This observation was tested in the context of a competition assay between the above mentioned variants. The results showed that the replication of the BF Vpu-harboring variant was more efficient in cell cultures than subtype B, reaching a higher frequency in the viral population in a short period of time.

CONCLUSION

This study showed that as a result of intersubtype recombination, a structurally re-organized HIV-1 Vpu has an improved in vitro capacity of enhancing viral replication, and provides evidence of the changes occurring in this protein function that could play an important role in the successful spread of intersubtype recombinant variants.

摘要

背景

在人类群体中已经发现了多种 HIV-1 亚型重组体。我们实验室小组的先前研究表明,阿根廷的流行情况以高流行循环重组形式 CRF12_BF 和许多相关 BF 重组形式为特征。在这些基因组结构中,重组断点经常涉及 vpu 编码区。由于对 Vpu 在病毒粒子释放过程中的参与及其对发病机制和亚型间重组 Vpu 蛋白的功能能力的了解甚少,因此本工作的目的是对携带 BF 重组 Vpu 或亚型 B Vpu 的病毒变体的病毒粒子释放能力和相对复制能力进行比较分析。

结果

我们的结果表明,与表达 tetherin 的细胞系中的 WT B 变体相比,BF 重组 Vpu 与病毒粒子产生的增加有关。在上述变体之间的竞争测定中对该观察结果进行了测试。结果表明,BF Vpu 携带变体的复制在细胞培养物中比亚型 B 更有效,在短时间内可在病毒群体中达到更高的频率。

结论

这项研究表明,由于亚型间重组,结构上重新组织的 HIV-1 Vpu 增强了体外病毒复制的能力,并为该蛋白功能发生的变化提供了证据,这可能在成功传播亚型间重组变体中发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3964/2967538/03ca992b06df/1743-422X-7-259-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3964/2967538/5b5747f4b05e/1743-422X-7-259-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3964/2967538/07d5817ddcb2/1743-422X-7-259-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3964/2967538/deddc346bb6b/1743-422X-7-259-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3964/2967538/03ca992b06df/1743-422X-7-259-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3964/2967538/5b5747f4b05e/1743-422X-7-259-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3964/2967538/07d5817ddcb2/1743-422X-7-259-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3964/2967538/deddc346bb6b/1743-422X-7-259-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3964/2967538/03ca992b06df/1743-422X-7-259-4.jpg

相似文献

1
Viral replication is enhanced by an HIV-1 intersubtype recombination-derived Vpu protein.病毒复制受 HIV-1 亚型间重组衍生的 Vpu 蛋白增强。
Virol J. 2010 Oct 4;7:259. doi: 10.1186/1743-422X-7-259.
2
Human immunodeficiency virus-1 BF intersubtype recombinant viral protein U second α helix plays an important role in viral release and BST-2 degradation.人类免疫缺陷病毒-1 BF 亚型间重组病毒蛋白 U 的第二个α螺旋在病毒释放和 BST-2 降解中发挥重要作用。
J Gen Virol. 2013 Apr;94(Pt 4):758-766. doi: 10.1099/vir.0.047746-0. Epub 2012 Dec 5.
3
Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue.Vpu 丝氨酸 52 依赖性对抗 tetherin 对于 HIV-1 在巨噬细胞中的复制是必需的,但在 ex vivo 人淋巴组织中不是必需的。
Retrovirology. 2010 Jan 15;7:1. doi: 10.1186/1742-4690-7-1.
4
Antagonism of CD317 restriction of human immunodeficiency virus type 1 (HIV-1) particle release and depletion of CD317 are separable activities of HIV-1 Vpu.HIV-1 Vpu 的拮抗作用可限制 HIV-1 病毒颗粒的释放,同时耗尽 CD317,这是 HIV-1 Vpu 的两种可分离的活性。
J Virol. 2010 Apr;84(8):4089-94. doi: 10.1128/JVI.01549-09. Epub 2010 Feb 10.
5
Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences.通过对近全长基因组序列的分析揭示了来自阿根廷的人类免疫缺陷病毒1型BF亚型间重组病毒的镶嵌结构多样性和共同起源。
J Gen Virol. 2002 Jan;83(Pt 1):107-119. doi: 10.1099/0022-1317-83-1-107.
6
Various plus unique: Viral protein U as a plurifunctional protein for HIV-1 replication.多样且独特:病毒蛋白U作为HIV-1复制的多功能蛋白
Exp Biol Med (Maywood). 2017 Apr;242(8):850-858. doi: 10.1177/1535370217697384. Epub 2017 Jan 1.
7
Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism.Vpu通过一种依赖βTrCP的机制指导人类免疫缺陷病毒限制因子BST-2/拴系蛋白的降解。
J Virol. 2009 Aug;83(16):7931-47. doi: 10.1128/JVI.00242-09. Epub 2009 Jun 10.
8
Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance.Vpu介导的对束缚蛋白的对抗作用是HIV-1干扰素抗性的主要决定因素。
mBio. 2016 Aug 16;7(4):e00934-16. doi: 10.1128/mBio.00934-16.
9
Human-Specific Adaptations in Vpu Conferring Anti-tetherin Activity Are Critical for Efficient Early HIV-1 Replication In Vivo.Vpu 中的人类特异性适应性赋予抗栓蛋白活性,对于 HIV-1 在体内的有效早期复制至关重要。
Cell Host Microbe. 2018 Jan 10;23(1):110-120.e7. doi: 10.1016/j.chom.2017.12.009.
10
The Vpu protein: new concepts in virus release and CD4 down-modulation.Vpu蛋白:病毒释放和CD4下调的新概念。
Curr HIV Res. 2010 Apr;8(3):240-52. doi: 10.2174/157016210791111124.

引用本文的文献

1
A high HIV-1 strain variability in London, UK, revealed by full-genome analysis: Results from the ICONIC project.全基因组分析揭示英国伦敦HIV-1毒株高度变异性:ICONIC项目的结果
PLoS One. 2018 Feb 1;13(2):e0192081. doi: 10.1371/journal.pone.0192081. eCollection 2018.
2
The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell Transmission.HIV-1 C亚型的包膜细胞质尾通过低病毒感染性和细胞间传播导致复制能力低下。
PLoS One. 2016 Sep 6;11(9):e0161596. doi: 10.1371/journal.pone.0161596. eCollection 2016.
3
Recombination in viruses: mechanisms, methods of study, and evolutionary consequences.

本文引用的文献

1
Identification of amino acids within the second alpha helical domain of the human immunodeficiency virus type 1 Vpu that are critical for preventing CD4 cell surface expression.鉴定人类免疫缺陷病毒 1 型 Vpu 第二α螺旋结构域中对防止 CD4 细胞表面表达至关重要的氨基酸。
Virology. 2010 Feb 5;397(1):104-12. doi: 10.1016/j.virol.2009.10.048. Epub 2009 Nov 27.
2
Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.Tetherin 驱动的 Vpu 和 Nef 功能适应以及大流行和非大流行 HIV-1 株的进化。
Cell Host Microbe. 2009 Nov 19;6(5):409-21. doi: 10.1016/j.chom.2009.10.004.
3
病毒中的重组:机制、研究方法及进化后果
Infect Genet Evol. 2015 Mar;30:296-307. doi: 10.1016/j.meegid.2014.12.022. Epub 2014 Dec 23.
4
Genetic characterization of natural variants of Vpu from HIV-1 infected individuals from Northern India and their impact on virus release and cell death.印度北部 HIV-1 感染者中 Vpu 天然变异的遗传特征及其对病毒释放和细胞死亡的影响。
PLoS One. 2013;8(3):e59283. doi: 10.1371/journal.pone.0059283. Epub 2013 Mar 28.
5
IL-12 and GM-CSF in DNA/MVA immunizations against HIV-1 CRF12_BF Nef induced T-cell responses with an enhanced magnitude, breadth and quality.IL-12 和 GM-CSF 在 DNA/MVA 免疫接种中增强了 HIV-1 CRF12_BF Nef 诱导的 T 细胞应答的幅度、广度和质量。
PLoS One. 2012;7(5):e37801. doi: 10.1371/journal.pone.0037801. Epub 2012 May 24.
6
Characterization of primary isolates of HIV type 1 CRF28_BF, CRF29_BF, and unique BF recombinants circulating in São Paulo, Brazil.对在巴西圣保罗流行的1型艾滋病毒CRF28_BF、CRF29_BF主要分离株及独特BF重组体的特征分析。
AIDS Res Hum Retroviruses. 2012 Sep;28(9):1082-8. doi: 10.1089/AID.2011.0123. Epub 2012 Apr 16.
HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes.
HIV-1 辅助蛋白 Vpu 通过跨膜相互作用内化细胞表面的 BST-2/ tetherin,导致溶酶体。
J Biol Chem. 2009 Dec 11;284(50):35060-72. doi: 10.1074/jbc.M109.058305. Epub 2009 Oct 16.
4
Human cellular restriction factors that target HIV-1 replication.靶向HIV-1复制的人类细胞限制因子。
BMC Med. 2009 Sep 16;7:48. doi: 10.1186/1741-7015-7-48.
5
HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation.HIV-1 Vpu通过与抗病毒因子Tetherin/BST-2结合并引导其依赖β-TrCP2的降解来中和该因子。
PLoS Pathog. 2009 Sep;5(9):e1000574. doi: 10.1371/journal.ppat.1000574. Epub 2009 Sep 4.
6
Characterization of DNA and MVA vectors expressing Nef from HIV-1 CRF12_BF revealed high immune specificity with low cross-reactivity against subtype B.对表达来自 HIV-1 CRF12_BF 的 Nef 的 DNA 和 MVA 载体进行了表征,结果表明,它们具有针对亚型 B 的低交叉反应性的高免疫特异性。
Virus Res. 2009 Dec;146(1-2):1-12. doi: 10.1016/j.virusres.2009.08.004. Epub 2009 Aug 26.
7
In vitro dynamics of HIV-1 BF intersubtype recombinants genomic regions involved in the regulation of gene expression.HIV-1 BF亚型间重组体中参与基因表达调控的基因组区域的体外动力学
Virol J. 2009 Jul 16;6:107. doi: 10.1186/1743-422X-6-107.
8
Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism.Vpu通过一种依赖βTrCP的机制指导人类免疫缺陷病毒限制因子BST-2/拴系蛋白的降解。
J Virol. 2009 Aug;83(16):7931-47. doi: 10.1128/JVI.00242-09. Epub 2009 Jun 10.
9
Vpu matchmakers as a therapeutic strategy for HIV infection.Vpu配对分子作为一种治疗HIV感染的策略。
PLoS Pathog. 2009 May;5(5):e1000246. doi: 10.1371/journal.ppat.1000246. Epub 2009 May 29.
10
Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking.Vpu通过β-TrCP和内吞溶酶体运输拮抗BST-2介导的HIV-1释放限制。
PLoS Pathog. 2009 May;5(5):e1000450. doi: 10.1371/journal.ppat.1000450. Epub 2009 May 29.